p. 1667−1670
2476-762X
Vol.22/No.6
p. 1671−1684
2476-762X
Vol.22/No.6
p. 1685−1693
2476-762X
Vol.22/No.6
p. 1695−1702
2476-762X
Vol.22/No.6
p. 1703−1712
2476-762X
Vol.22/No.6
p. 1713−1720
2476-762X
Vol.22/No.6
p. 1721−1729
2476-762X
Vol.22/No.6
5 cm (P < 0.0001), tumor nodules > 3(P=0.01), and macrovascular invasion(p <0.0001). The high risk group (patients with AFP ≥ 40 ng/ml + PIVKAII ≥ 350 mAU/ml), had a sensitivity of (23/33) 69.6% and specificity of (22/22)100% for MVI (P <0.001). The estimated 3 year RFS after LT in the low risk group (AFP ]]>
p. 1731−1736
2476-762X
Vol.22/No.6
p. 1737−1744
2476-762X
Vol.22/No.6
p. 1745−1751
2476-762X
Vol.22/No.6
p. 1753−1759
2476-762X
Vol.22/No.6
p. 1761−1766
2476-762X
Vol.22/No.6
p. 1767−1774
2476-762X
Vol.22/No.6
p. 1775−1780
2476-762X
Vol.22/No.6
p. 1781−1787
2476-762X
Vol.22/No.6
p. 1789−1797
2476-762X
Vol.22/No.6
p. 1799−1811
2476-762X
Vol.22/No.6
p. 1813−1819
2476-762X
Vol.22/No.6
0.05). The IFN-γR (-611 IFN-γ) AA genotype significantly increased risk of HCC (OR= 0.78, 95% CI= 0.10-6.39; P= 0.042). Conclusion: The analysis of IFN-γR -611 single nucleotide gene polymorphism could be a valuable marker for predicting subgroup of cirrhotic patients with high risk of developing HCC. Cirrhotic patients have AA genotype of IFN-γR-611 recommended to be under close follow up.]]>
p. 1821−1826
2476-762X
Vol.22/No.6
2). In addition, CCA-1.1 demonstrated a synergistic effect in combinatorial treatment with a low dose of doxorubicin. A single treatment of CCA-1.1 repressed cell migration in 4T1 and MCF-7/HER2 cells. Under gelatin zymography, CCA-1.1 subsided the activities of MMP-9, thereby revealing the potency of CCA-1.1 as an anti-migratory agent. Moreover, MMP-9 was also eminently expressed in TNBC and HER2-enriched breast cancer cells when compared with that in other subtypes. Conclusion: Our preliminary study collectively reinforces the potential effect of CCA-1.1 through the inhibition of highly aggressive cell migration, particularly in breast cancer.]]>
p. 1827−1836
2476-762X
Vol.22/No.6
p. 1837−1841
2476-762X
Vol.22/No.6
p. 1843−1849
2476-762X
Vol.22/No.6
p. 1851−1855
2476-762X
Vol.22/No.6
0.05). Conclusion: Herbal therapy did improve the QoL of cancer patients in the southern region of Peninsular Malaysia.]]>
p. 1857−1863
2476-762X
Vol.22/No.6
p. 1865−1868
2476-762X
Vol.22/No.6
p. 1869−1873
2476-762X
Vol.22/No.6
p. 1875−1881
2476-762X
Vol.22/No.6
p. 1883−1889
2476-762X
Vol.22/No.6
p. 1891−1898
2476-762X
Vol.22/No.6
p. 1899−1905
2476-762X
Vol.22/No.6
p. 1907−1912
2476-762X
Vol.22/No.6
p. 1913−1920
2476-762X
Vol.22/No.6
p. 1921−1926
2476-762X
Vol.22/No.6
p. 1927−1933
2476-762X
Vol.22/No.6
p. 1935−1942
2476-762X
Vol.22/No.6
p. 1943−1948
2476-762X
Vol.22/No.6
p. 1949−1955
2476-762X
Vol.22/No.6
55years) were used as controls. Annotations of the CNV regions which were observed were done using the database of Genomic Variants. Results: We identified 150 CNVs including regions of both genomic gains and losses in the patient cohort. There was no difference in the average number or the average genomic burden of CNVs identified in the patients versus the controls. CNVs were residing on the positions of 1q21.2, 2q37.3, 2p11.2-p11.1, 5q13.2, 6p12.3, 7q31.33, 7p14.1, 14q32.33, 15q11.1-11.2, 16p11.2, 22q11.22, 22q13.1 that were assessed by the array platform used in the study. CNVs in any of the well-known common CPG s or CNVs that reside on or in close proximity to genes corresponding to MMR pathway were not identified. We found several distinct pathways that have previously been identified as having a direct association with the progression of HNPCC. Conclusion: This study shows that CNVs are likely contributors to the colorectal cancer predisposition in a small but significant proportion of patients affected with hereditary colorectal cancer in this cohort. Further studies have to perform to get a better understanding on the contribution of CNVs to the cancer predisposition in this cohort of patients in the Sri Lankan population.]]>
p. 1957−1966
2476-762X
Vol.22/No.6
p. 1967−1973
2476-762X
Vol.22/No.6
p. 1975−1984
2476-762X
Vol.22/No.6